While the use of ultrasound to identify tumors during kidney cancer surgery is gaining acceptance, a research team at Henry Ford Hospital has successfully taken it a step further by showing an added benefit when the procedure is done robotically.
Aptus Endosystems, Inc., a medical device company developing advanced technology for endovascular aneurysm repair (EVAR), announced today that its ANCHOR post-market registry enrollment has surpassed its key milestone of 250 patients.
Halt Medical Announces New CPT® Code From the American Medical Association for RF Ablation of Uterine FibroidsJuly 10, 2013 3:00 am | by PR Newswire | News | Comments
Halt Medical is very pleased to announce that the American Medical Association (AMA) Current Procedure Terminology (CPT) Panel has established a new CPT® code specifically for Radiofrequency (RF) Ablation of Uterine Fibroids. CPT codes are used by medical practitioners; including physicians, hospitals, and other healthcare providers to report healthcare services to insurers for the purpose of reimbursement.
PRO-DEX, INC. (Nasdaq: PDEX), a leading medical device developer and manufacturer of world-class powered surgical devices, has partnered with UC Irvine's The Henry Samueli School of Engineering to offer graduating seniors the opportunity to work alongside industry veterans in the design and manufacture of next-generation medical devices.
LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that on July 5, 2013 it acquired the assets of Clinical Instruments International, Inc. for $1.1mm, or 1.7X 2012 sales. Clinical Instruments is based in Southbridge, MA and manufactures carotid shunts and embolectomy catheters.
Aesculap Implant Systems announced today the availability of the new Quintex Anterior Cervical Plating System, today’s most versatile system for use in ACDF procedures at multiple levels from C2-T1. Quintex was designed to address all plating ideologies and offers construct options ranging from fully rigid to dynamic, including the new Semidynamic™ option, unique to Aesculap Implant Systems’.
Intuitive Surgical took a nearly 12% hit in after-hours trading today after the medical device company said it expects to miss its 2nd-quarter sales forecast. The Sunnyvale, Calif.-based robotic surgery company said it expects to post sales of roughly $575 million, up 7.3% from the 2nd quarter of 2012 but well shy of analysts' $630 million expectations.
Michael Feiz, M.D., F.A.C.S believes that it's becoming clear that the prevention of cancer is another major benefit of healthy, long-term weight loss that can be fostered by such bariatric procedures as the sleeve gastrectomy and the Lap Band. Obese people are used to hearing warnings regarding heart disease, high blood pressure, diabetes, and stroke; however, the link between obesity and cancer is often left out of the discussion.
Dr. Jie Zheng and Dr. Robert Weiss are among the most recent to contribute to the growing research of hydrogels, the gelatinous substance that, because of its toughness and plasticity, has several biomedical applications, including cartilage repair, implants for minimally invasive surgery and drug delivery.
Early-stage device company Dallen Medical announced a 1st-in-man study of its Compressyn band, a breast-plate wire closure device designed to help stabilize patients after open heart surgery. After the sternum is cracked during open-heart surgery, patients require specialized wires to hold the cavity together.
Life Care Medical Devices Signs Exclusive Agreement with M.E.D. Surgical for the Distribution in Ireland of its Proprietary Keyhole Cup@ Laparoscopic Access DeviceJuly 8, 2013 8:45 am | by The Associated Press | News | Comments
Life Care Medical Devices Ltd., (OTC BB: LCMD), a development stage medical device company today announced that Life Care Medical Devices, Ltd, Ireland signed an exclusive agreement with M.E.D. Surgical, a subsidiary of Sisk Healthcare for the distribution of the Company's Keyhole Cup@ ...
North Carolina medical device maker Baxano Surgical Inc. (NSDQ:BAXS) agreed to pay $6 million to close a Justice Dept. probe initiated nearly 2 years ago. The definitive settlement consummates a tentative agreement the spinal device company forged with federal regulators in December 2012, according to a Baxano Surgical statement.
Medtronic (NYSE:MDT) prevailed in an antitrust lawsuit filed over a bone mill made by Lenox MacLaren Surgical, with a federal judge ruling that Lenox misrepresented the size of the bone mill market and failed to adequately market its own device.
Blaze Biosciences is more than halfway to a targeted $15 million in a Series B round to fund its Tumor Paint, a surgical tool that visually distinguishes solid tumor cells from healthy cells. Founded in 2010, the Seattle, Wash.-based Blaze Biosciences has roped in about $8.1 million since opening the round in June.
ArthroCare (NSDQ:ARTC) said it closed its $45 million acquisition of ENTrigue Surgical and bought a nearly 20% stake in Israeli medical device company Ortho-Space. The deal price for ENTrigue, which makes a device to treat chronic sinusitis, includes "contingent consideration" pegged to sales growth milestones, according to a press release.
Some 55 U.S. hospitals agreed to pay a total of $34 million to settle U.S. Justice Dept. charges that they overcharged Medicare for Medtronic's (NYSE:MDT)'s kyphoplasty spine procedure, acquired in the $3.9 billion buyout of Kyphon in 2007, the Justice Dept. said today.
Minnesota medical device giant Medtronic (NYSE:MDT) confirmed today that it recalled certain of its already-troubled Infuse spinal fusion surgery kits after learning of possible contamination in sponges manufactured by Integra Lifesciences.
SpineGuard announced today that it has obtained regulatory clearance from COFEPRIS (the Mexican healthcare regulatory authority) to sell its Cannulated PediGuard® device in Mexico. SpineGuard has previously received clearance for its Classic PediGuard device, and over 50 Mexican spine surgeons have been trained on the technology.
A study by researchers at Hospital for Special Surgery has provided the first evidence that the shape of a person's knee could be a factor in the decision of whether a patient should undergo anterior cruciate ligament reconstruction after an ACL tear.
ArthroCare Corp. (NASDAQ: ARTC), a leader in developing state-of-the-art, minimally invasive surgical products, today announced that it has completed the acquisition of ENTrigue Surgical, Inc., a privately held Delaware corporation (“ENTrigue”), in an all cash transaction.
Dallen Medical Initiates “First-in-Man” Clinical Study of its Compressyn™ Band Sternal Closure DeviceJuly 2, 2013 8:00 am | by Business Wire | News | Comments
Dallen Medical, an emerging medical device company, announced today that the first three patients have been treated using its proprietary Compressyn™ Band sternal closure device. The first Compressyn device used for stabilization and rigid fixation following open heart procedures was performed by Dr. Joseph Wilson of Eisenhower Medical Center.
ZOLL Medical Corporation has purchased the assets of CoAxia, an early revenue stage medical device company that provides catheter-based perfusion augmentation therapies to improve outcomes for patients with cerebral ischemia resulting from vasospasm, following subarachnoid hemorrhage.
Is it possible, that in 2-3 years Brits, Germans, Scandinavians, and Russians will undergo cancer treatment, orthopaedic, or cardiac surgery procedures in Polish medical facilities more often? Treat teeth and get implants in dental clinics; take a cure in Polish sanatoriums?
Engineers from Queen Mary, University of London have developed the most precise computer simulation of how red blood cells might travel around the body to help doctors treat people with serious circulatory problems. Understanding how damaged red blood cells might interact with each other or their neighboring cells could be useful in realizing blood flow in patients who are diabetic or have had surgery to address circulation complications.
When a breast tumor is detected, many women opt to have a lumpectomy, which is surgery designed to remove the diseased tissue while preserving the breast. But during this procedure, doctors cannot learn right away whether all of the cancerous tissue has been removed, with no microscopic signs that cancer cells were left behind.